Retatrutide
Weight controlRetatrutide is an incretin-agonist peptide that acts simultaneously on three receptors: GIP, GLP-1, and glucagon. One of the most actively researched peptides right now in the Weight Control category.
A triple mechanism
Unlike compounds acting only on the GLP-1 receptor, this "triple" agonism is being studied as a way to influence energy metabolism more strongly by combining several appetite-, insulin-sensitivity-, and energy-expenditure-regulating pathways at once.
What matters before starting
The incretin-agonist class is developing fast: new data on tolerability profile and dosing protocols is published regularly. Any protocol in this category should be discussed with a doctor if it involves actual use rather than just reading the literature — compounds in this class have a noticeable effect on metabolism.
Questions about Retatrutide
How is retatrutide different from other incretin agonists?
It acts simultaneously on three receptors — GIP, GLP-1, and glucagon — whereas many other compounds in this class act on only one or two of them.
Do I need a doctor's consultation?
Yes. Compounds in this class have a noticeable effect on metabolism — discuss any protocol with a specialist, not just based on site materials.
Exact prices, dosages, and availability are in the Telegram catalog.
Open in Telegram